<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01997502</url>
  </required_header>
  <id_info>
    <org_study_id>494171</org_study_id>
    <nct_id>NCT01997502</nct_id>
  </id_info>
  <brief_title>Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb</brief_title>
  <official_title>Prospective Observational Study Characterizing Noninvasive Hemoglobin (SpHb) Measured With Pulse CO-Oximetry Technology in a Variety of Surgical Cases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This protocol is a request from Masimo to assist in the collection of data to be used to
      further refine the accuracy of the monitor's algorithm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific aim of this study is to collect data to characterize Masimo's noninvasive
      Rainbow SpHb technology during surgeries. The purpose is to compare Masimo Rainbow technology
      to arterial blood samples taken during surgery. Hemoglobin concentrations in the arterial
      blood samples will be measured using standard blood analyzers on site and/or the sponsor's
      laboratory.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 26, 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Masimo Rainbow technology to arterial blood samples taken during surgery</measure>
    <time_frame>Five year</time_frame>
    <description>Correlation between standard, lab-based, hemoglobin measurement and concurrent SpHb.</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Surgery</condition>
  <condition>Hemoglobin</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulse CO-Oximetry Technology</intervention_name>
    <description>In addition to the standard pulse oximeter used for clinical care, up to six SpHb finger sensors will be applied to the patient. Additional sensors may also be applied to the forehead, neck, chest and ears.
Masimo FDA cleared pulse CO-Oximeter devices: Radical-7, Rad-87, Rad-57, Pronto, Pronto-7, for the noninvasive measurement of SpO2, PR, PI, PVI, SpCO, SpMet, and SpHb, total hemoglobin and respiratory rate.
No treatment decisions will be made based on the new technology and no extra medical procedures are required for the study.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>4mL arterial blood samples (up to 1 per hour), outside standard of care, are drawn throughout the surgical procedure and sent to UCDMC lab/Masimo lab for analysis.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective surgery requiring intra-arterial pressure monitoring

        Exclusion Criteria:

          -  Age less than 18 years

          -  Pregnancy

          -  Prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neal Fleming, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor, Director, Cardiovascular and Thoracic Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neal W Fleming, M.D., Ph.D.</last_name>
    <phone>916-734-5394</phone>
    <email>nwfleming@ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana Arias, BS</last_name>
    <phone>916-703-5456</phone>
    <email>apaarias@ucdavis.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UC Davis Health</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neal W Fleming, M.D., Ph.D.</last_name>
      <phone>916-734-5394</phone>
      <email>nwfleming@ucdavis.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ana Arias, BS</last_name>
      <phone>916-703-5456</phone>
      <email>apaarias@ucdavis.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Neal W Fleming, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2013</study_first_submitted>
  <study_first_submitted_qc>November 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2013</study_first_posted>
  <last_update_submitted>May 24, 2017</last_update_submitted>
  <last_update_submitted_qc>May 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hemoglobin</keyword>
  <keyword>Non-invasive</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

